Previous 10 | Next 10 |
SALT LAKE CITY, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease usin...
Score Media and Gaming (NASDAQ:SCR) +65% Penn National Gaming inks deal to acquire Score Media and Gaming Ensysce Biosciences (NASDAQ:ENSC) +38% announces notice of allowance from the U.S. Patent and trademark office for Patent entitled “compositions comprising enzyme-cl...
Clene (NASDAQ:CLNN) soars 25% premarket after announcing positive top-line results from the Phase 2 REPAIR clinical trials investigating the improvement of brain energetic metabolism in Parkinson’s disease (PD) and multiple sclerosis (MS). The objective of the REPAIR cli...
Achieved a statistically significant increase in the Phase 2 program’s primary endpoint (mean change in brain NAD+/NADH ratio) CNM-Au8 ® , a gold nanocrystal suspension, significantly improved brain energetic metabolism Trial results demonstrate...
Clene is a developer of proprietary, patented, nanocatalysis therapy for neurodegenerative diseases. They have ongoing phase 2 trials in multiple sclerosis, Parkinson’s disease and amyotrophic lateral sclerosis. Current stock price near 52-week low offers decent opening. ...
SALT LAKE CITY, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company dedicated to the treatment of neurodegenerative disease usin...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Before the novel coronavirus pandemic upended our paradigm, financial advisors bemoaned that millennials and Generation Z were falling behind prior generations regarding achieving certain financial milestones. Suddenly, tho...
Gainers: Clene (CLNN) +8%, Inhibikase Therapeutics (IKT) +7%, ASLAN Pharmaceuticals (ASLN) +5%, Doximity (DOCS) +5%.Losers: IMV (IMV) -26%, Tempest Therapeutics (TPST) -25%, Sonoma Pharmaceuticals (SNOA) -23%, Immunic (IMUX) -18%, Virpax ...
MediaCo (MDIA) +312%.State Auto Financial (STFC) +191%.SGOCO (SGOC) +104%.SCWorx (WORX) +59%.Tempest (TPST) +54%.Origin Agritech (SEED) +41%.Datasea (DTSS) +39%.Creatd (CRTD) +33%.Cemtrex (CETX) +32%.Ayala Pharmaceuticals (AYLA) +29%.Celldex Therapeutics (CLDX) +25%.Baosheng Media (BAOS) +25%...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short-squeeze stocks are making headlines as the collective action of the Reddit community provides positive momentum for their share prices. However, many dive into these stocks without researching tangible data. Therefore...
News, Short Squeeze, Breakout and More Instantly...
Clene plans to submit a briefing book to the U.S. Food and Drug Administration by July 13 as Part of Overall Process to Support Approval for CNM-Au8(R) for Treatment of ALS Type C interaction is aimed at obtaining FDA feedback on the potential pathway for a new drug application for CNM-Au8 as a...
Latest figures from the World Health Organization show that more than 8.5 million individuals around the globe are living with Parkinson’s disease . This disease is the fastest-growing neurodegenerative disorder globally, with the number of individuals with this illness more than doubli...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...